Hypophosphataemia after Bexagliflozin (Bexacat) in cats

26 reports to the FDA describe hypophosphataemia in cats given Bexagliflozin. That is 0.6% of all reports for this medicine, compared with 0.2% across reports for all cat medicines, so it is reported unusually often with this medicine.

26Reports

88%Marked serious

0.0%Recovered

58%Died or euthanised

3 daysTypical onset

How soon it started

Same day

4 20%

1–2 days

5 25%

3–7 days

5 25%

1–4 weeks

3 15%

Over a month

3 15%

How the animals did

Still unwell when reported

8 31%

Died

1 3.8%

Euthanised

14 54%

Not known

3 12%

Problems reported at the same time

21 81%

19 73%

18 69%

15 58%

Diabetic ketoacidosis

14 54%

Ketosis

13 50%

Hyperglycaemia

13 50%

Lethargy

12 46%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Bexagliflozin treats diabetes in cats (oral, an SGLT2 inhibitor).

Products with this ingredient include Bexacat. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Bexagliflozin cause hypophosphataemia in cats?: 26 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 3 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Hypophosphataemia with similar medicines

Hypophosphataemia after Velagliflozin (Senvelgo) 51 reports · 1.1% of its reports

All reported side effects of Bexagliflozin in cats · Medicines most reported with hypophosphataemia